Argen X SE Gross Profit

The latest gross profit for ARGX is $6.2B as of June 2026. That compares with $2.3B in the prior-year period — up 170.2% year over year. That is below the Healthcare sector average of $66B. Investors often review this figure alongside Argen X SE's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARGX's gross profit moved from $2.3B to $6.2B — a 170.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Argen X SE's operating scale or balance-sheet position.

Against Healthcare companies, ARGX currently prints $6.2B for gross profit, while the sector average sits near $66B. That is roughly 90.5% below the sector mean. Large gaps often invite a closer look at Argen X SE's growth, margins, and balance sheet.

A gross profit figure of $6.2B for ARGX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $66B. Explore the charts below for those layers of context.

After noting ARGX's gross profit ($6.2B), review year-over-year change from $2.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.